KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) EBT Margin (2016 - 2025)

Amgen has reported EBT Margin over the past 17 years, most recently at 15.35% for Q4 2025.

  • Quarterly results put EBT Margin at 15.35% for Q4 2025, up 674.0% from a year ago — trailing twelve months through Dec 2025 was 24.42% (up 1063.0% YoY), and the annual figure for FY2025 was 24.42%, up 1063.0%.
  • EBT Margin for Q4 2025 was 15.35% at Amgen, down from 41.03% in the prior quarter.
  • Over the last five years, EBT Margin for AMGN hit a ceiling of 380.83% in Q4 2022 and a floor of 0.91% in Q1 2024.
  • Median EBT Margin over the past 5 years was 25.53% (2022), compared with a mean of 41.98%.
  • Biggest five-year swings in EBT Margin: soared 34970bps in 2022 and later tumbled -37043bps in 2023.
  • Amgen's EBT Margin stood at 31.13% in 2021, then skyrocketed by 1123bps to 380.83% in 2022, then crashed by -97bps to 10.4% in 2023, then fell by -17bps to 8.61% in 2024, then skyrocketed by 78bps to 15.35% in 2025.
  • The last three reported values for EBT Margin were 15.35% (Q4 2025), 41.03% (Q3 2025), and 17.08% (Q2 2025) per Business Quant data.